Related Experiment Video
Updated: Mar 1, 2026
07:55
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.9K
Immunotherapy for pancreatic cancer: present and future
Francesca Aroldi1, Alberto Zaniboni1
1UO Oncologia, Poliambulanza Foundation, Via Bissolati 57, 25124 Brescia, Italy.
Immunotherapy
|June 10, 2017
Summary
Pancreatic cancer is a lethal disease with high therapy resistance due to its unique tumor microenvironment. Investigating immunotherapies targeting innate or adaptive immunity offers promising future treatment directions for this challenging cancer.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- Pancreatic cancer is a highly lethal malignancy with significant therapeutic resistance.
- Its unique tumor microenvironment features immunosuppressive mediators and a dense stroma, hindering drug penetration and controlling immune responses.
Purpose of the Study:
- To review the current literature on pancreatic cancer treatment resistance.
- To explore the role of the immune system in pancreatic cancer.
- To hypothesize future therapeutic strategies, particularly immunotherapies.
Main Methods:
- Literature review of existing studies on pancreatic cancer treatment and immunotherapy.
- Analysis of the impact of the tumor microenvironment on therapeutic efficacy.
- Synthesis of current research findings to propose future directions.
Main Results:
- Pancreatic cancer exhibits strong resistance to conventional therapies.
- The tumor microenvironment plays a critical role in immune suppression and drug resistance.
- The immune system is a key factor in pancreatic cancer progression and response to treatment.
Conclusions:
- Immunotherapies targeting innate or adaptive immunity represent a promising avenue for overcoming treatment resistance in pancreatic cancer.
- Further research into modulating the pancreatic tumor microenvironment and immune system is crucial for developing effective treatments.
Related Concept Videos
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
01:30Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
01:29Chronic Pancreatitis II: Collaborative Care
439
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
439
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K